Kaizen Financial Strategies’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-9,040
Closed -$456K 124
2022
Q2
$456K Hold
9,040
0.45% 57
2022
Q1
$551K Buy
9,040
+100
+1% +$5.96K 0.43% 60
2021
Q4
$589K Hold
8,940
0.44% 56
2021
Q3
$561K Buy
+8,940
New +$570K 0.45% 61
2021
Q1
$492K Sell
8,940
-120
-1% -$6.66K 0.47% 64
2020
Q4
$494K Buy
+9,060
New +$474K 0.55% 55

Other funds holding IHI

Kaizen Financial Strategies's IHI Position: Q3 2022 in Review

Kaizen Financial Strategies sold out of iShares US Medical Devices ETF (IHI) in Q3 2022, closing a stake of 9,040 shares — an estimated $456K sold.

Kaizen Financial Strategies first reported a position in IHI in Q4 2020 and held it in 6 quarters. The position peaked at $589K in Q4 2021. 556 funds tracked by Wall St. Rank hold IHI as of Q3 2022.

  • Kaizen Financial Strategies reported no remaining iShares US Medical Devices ETF position as of Q3 2022 after selling out during the quarter.
  • Kaizen Financial Strategies sold 9,040 iShares US Medical Devices ETF shares in Q3 2022, an estimated $456K.
  • Kaizen Financial Strategies first reported a position in iShares US Medical Devices ETF in Q4 2020 and held it in 6 quarters.
  • Kaizen Financial Strategies's iShares US Medical Devices ETF position peaked at $589K in Q4 2021.
  • 556 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q3 2022.

Based on Kaizen Financial Strategies's 13F filing for Q3 2022, filed 19 Oct 2022.